Study of the influenza virus vaccine, trivalent, types A & B, live cold-adapted in a community-based, non-randomized, open-label trial in children to assess safety and herd immunity for the control of epidemic influenza
Phase of Trial: Phase III
Latest Information Update: 14 Nov 2005
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 19 Oct 2005 New trial record.